Activism, antiretroviral drugs and reshaping of the self as forms of biopolitical citizenship
DOI:
https://doi.org/10.14672/ada2006147%25pKeywords:
activism, antiretroviral drugs, biopolitical citizenship, social suffering, AIDSAbstract
This article examines the intersection of activism, antiretroviral (ARV) drugs, and the reformation of the self as expressions of biopolitical citizenship. It explores the shift in HIV/AIDS activism from mere awareness and condom use to a direct engagement with the disease through increased HIV testing and treatment access. This transition, driven by the availability of ARV drugs, has led to the emergence of "therapeutic citizenship," where individuals' identities and societal roles are shaped by their health status and access to treatment.
The article discusses how ARV drugs have not only improved health outcomes but also fostered a form of social activism centered around the fight for medication access. This activism is linked to global inequalities, as the struggle for affordable ARVs highlights the complex dynamics of the global pharmaceutical industry and intellectual property laws. The paper also delves into the broader implications of this therapeutic activism, suggesting that it represents a form of modern biosociality, where social identities are increasingly tied to biological conditions and medical interventions. By analyzing the case of HIV in Africa, this article illustrates how therapeutic citizenship challenges traditional notions of identity and community, integrating biomedical advancements into the social fabric. This integration demonstrates how global health initiatives and local realities interact to reshape both individual lives and collective social structures.
Downloads
Published
Issue
Section
License
Copyright (c) 2013 Vinh-Kim Nguyen
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors maintain the copyright of their original work and grant the Journal the right to first publication, licensed after 36 months under a Creative Commons Licence – Attribution, which allows others to share the work by indicating the authorship and first publication in this journal.
Authors may agree to other non-exclusive licence agreements for the distribution of versions of their published work (for example in institutional archives or monographs) under the condition that they indicate that their work was first published in this journal.